Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia

BACKGROUND: There has been an increase in incidence and prevalence of inflammatory bowel disease (IBD) outside the western countries. Treatment costs are an essential component for healthcare planning and priority setting. The utilization patterns and annual administration and cost of IBD medication...

Descripción completa

Detalles Bibliográficos
Autores principales: AlRuthia, Yazed, Alharbi, Othman, Aljebreen, Abdulrahman M., Azzam, Nahla A., Almadi, Majid A., Bahari, Ohud H., Almalki, Khalid A., Atham, Abdulaziz T., Alanazi, Ahmed S., Saeed, Maria, HajkhderMullaissa, Baraa, Alsenaidy, Mohammad, Balkhi, Bander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894268/
https://www.ncbi.nlm.nih.gov/pubmed/31827409
http://dx.doi.org/10.1186/s12962-019-0194-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894268/
https://www.ncbi.nlm.nih.gov/pubmed/31827409
http://dx.doi.org/10.1186/s12962-019-0194-3

Ejemplares similares